Press Office

The therapeutic vaccines market is anticipated to grow at an annualized rate of more than 50% by 2035, claims Roots Analysis 

March 2023

Over time, therapeutic vaccines have generated significant interest in the pharmaceutical industry owing to their safety, specificity, augmented immunity and long-term cli... read more

The viral clearance and testing services market is anticipated to grow at a CAGR of ~10% till 2035, claims Roots Analysis 

March 2023

In order to avail benefits, such as technical competence, compliance with regulations, reduced production costs and on-time approval of biologics, innovators have shown prefe... read more

The Tissue Engineering-based Regeneration Products market is projected to grow at a CAGR of 9.17%, till 2035, claims Roots Analysis

March 2023

The present treatment landscape of chronic wound and bone healing is characterized by a variety of unmet needs; tissue engineering-based regeneration products have em... read more

The TCR-based therapy market is projected to grow at an annualized rate of 51%, claims Roots Analysis

February 2023

Given the recent approval of a TCR-based therapy, industry stakeholders have initiated several R&D efforts focused on evaluating the potential of such therapy candidates against various diseas... read more

The global cell cytometry market is anticipated to grow at a CAGR of ~10%, till 2035, claims Roots Analysis

February 2023

In order to accommodate the growing demand for higher accuracy, greater resolution and improved sensitivity in analytical processes, various industry stakeholders are engaged in the developm... read more

The long-acting drug delivery technologies market is projected to grow at a CAGR of 13%, till 2035, claims Roots Analysis 

February 2023

In order to mitigate the complexities associated with achieving a long-acting profile, drug developers have been inclined towards the utilization of long-acting drug delivery... read more

The viral vaccine cell culture media market is projected to grow at a CAGR of 6% during 2022-2035, claims Roots Analysis

February 2023

The recent surge in demand for vaccines amidst the COVID-19 pandemic has served to facilitate a strong case for organizations to opt for cell culture media for the development a... read more

The women’s digital health market is anticipated to grow at an annualized rate of more than 17% by 2035, claims Roots Analysis 

February 2023

The COVID-19 pandemic has led to an increase in the adoption of digital solutions, specifically among women, allowing remote monitoring of health and improvement in ov... read more

The Aptamers: Therapeutics, Technologies, and Services market is projected to grow at a healthy CAGR, claims Roots Analysis

February 2023

Upon realizing the numerous benefits offered by aptamers, industry stakeholders have undertaken several R&D initiatives focused on exploiting the use of aptamers for vari... read more

The T-cell immunotherapy market is projected to grow at an annualized rate of 23%, claims Roots Analysis 

February 2023

Driven by high success rates in clinical trials and the potential to confer sustained periods of disease remission, T-cell therapies have received significant financial support, with approved... read more

The minibioreactors and microbioreactors market is anticipated to grow at an annualized rate of 8% till 2035, claims Roots Analysis 

February 2023

Given the need for accelerated bioprocessing operations, low-volume bioreactors have emerged as a relatively economic solution for parallelized cell cultivations an... read more

The novel antibody therapies market for advanced stage drugs is anticipated to grow at a CAGR of 36% by 2035, claims Roots Analysis

February 2023

Owing to the recent approval of therapies, such as Elzonris®, Pluvicto®, there has been a substantial increase in the R&D activity to evaluate the use of ... read more

The nutrigenomics market is projected to grow at an annualized rate of 13%, during the period 2022-2035, claims Roots Analysis

February 2023

Driven by the growing awareness regarding the influence of diet on health and its potential to minimize diet-related disease risks, the nutrigenomics market is likely to w... read more

The viral vector, non-viral vector and gene therapy manufacturing market is projected to grow at a CAGR of ~15% till 2035, claims Roots Analysis 

February 2023

Rise in clinical research activity for genetically modified therapies has resulted in the increase in demand for vectors; offering lucrative opportunit... read more

The medical device coatings market is anticipated to grow at a steady CAGR of 7.7% till 2035, claims Roots Analysis

February 2023

Driven by the growing demand of medical devices, coupled with unique coating needs for each type of medical device, an increasing number of developers are leveraging the technical ex... read more

The mRNA synthesis and manufacturing market is projected to be worth USD 1.5 billion by 2035, claims Roots Analysis

February 2023

Given the current technical and operational challenges associated with the manufacturing of mRNA-based products, innovators in the biopharmaceutical industry are increasingly relying... read more

The TIL therapies market is projected to grow at an annualized rate of 40%, claims Roots Analysis 

February 2023

Owing to their tumor-killing capability and therapeutic superiority to conventional therapies, TIL therapies are being actively evaluated to treat advance, incurable oncological disorders by various... read more

The blockchain in drug discovery and clinical trials market is anticipated to grow at a CAGR of over 20% till 2035, claims Roots Analysis

February 2023

Blockchain has emerged as a viable solution for management / exchange of large volumes of healthcare data, demonstrating significant benefits in the healthcare ... read more

The DNA synthesis services market is anticipated to grow at an annualized rate of more than 15% by 2035, claims Roots Analysis 

January 2023

With growing applications of DNA in medical research, industry stakeholders are actively looking for technologies that not only facilitate parallelized synthesis of DNA ... read more

The continuous manufacturing market is projected to grow at an annualized rate of 17.3% during the period 2022-2035, claims Roots Analysis

January 2023

In comparison to batch production methods, continuous manufacturing is not only cost and time-efficient, but also enables reduction in energy and manpower requ... read more

The Artificial Intelligence in Oncology market is anticipated to grow at a CAGR of 54% claims Roots Analysis

December 2022

The success of currently employed artificial intelligence (AI) solutions has encouraged researchers to explore the potential of such technologies in the healthcare sector, with its prime fo... read more

The automatic sampling systems market is anticipated to grow at a CAGR of over 15% by 2035, claims Roots Analysis

December 2022

Given the advanced features and cost saving potential, automatic sampling systems have been widely adopted by various stakeholders in biopharmaceutical industry, to monitor data in rea... read more

The antibody discovery services and platforms market is projected to grow at an annualized rate of over 20% by 2035, claims Roots Analysis

December 2022

Given the high target specificity and favorable safety profiles offered by antibody based pharmacological interventions, the antibody discovery market has witn... read more

Aptamers therapeutics, technologies and services market is projected to grow at a healthy CAGR, claims Roots Analysis

September 2022

Upon realizing the numerous benefits offered by aptamers, industry stakeholders have undertaken several R&D initiatives focused on exploiting the use of aptamers for various pu... read more

The ADC contract manufacturing market is projected to grow at a CAGR of more than 13% till 2035, claims Roots Analysis

September 2022

Owing to the fact that a number of ADC developers are outsourcing various aspects of their business processes, CMOs engaged in this domain have undertaken several expansion initia... read more

The DNA and gene cloning services market is anticipated to grow at a CAGR of over 15% by 2035, claims Roots Analysis

September 2022

In order to avail benefits, such as technical competence, reduced cost, and fast delivery of high-quality DNA and gene customized clones, several players have demonstrated a prefere... read more

The single-use downstream bioprocessing technology market is anticipated to grow at CAGR of 10% till 2035, claims Roots Analysis 

September 2022

Given the increased demand for biologics and various benefits of single-use technology, the biopharmaceutical manufacturers are gradually adopting single-use systems f... read more

The singe-use upstream bioprocessing technology market is projected to  grow at a CAGR of 12% till 2035, claims Roots Analysis 

September 2022

Given the various benefits of single-use technology and the rising demand for biologics, the biopharmaceutical industry is gradually shifting from conventional manufact... read more

The AI-based drug discovery market is projected to grow at an annualized rate of 25%, during the period 2022-2035, claims Roots Analysis

September 2022

Stakeholders in the pharmaceutical industry are currently exploring the implementation of artificial intelligence (AI) based tools to expedite drug discovery tim... read more

The RNAi therapeutics and technologies market is anticipated to grow at a CAGR of 20%, till 2035, claims Roots Analysis

August 2022

The success of currently approved RNAi drugs has encouraged researchers to explore the therapeutic potential of RNAi therapeutics and associated technologies, enabling their impl... read more

The biosensors market focused on drug discovery and development is projected to grow at an annualized rate of 9% during the period 2022-2035, claims Roots Analysis

August 2022

In recent years, the use of biosensors in drug discovery has been on the rise, driven by several technological advancements and the gr... read more

The companion diagnostics development services market, is anticipated to grow at a CAGR of over 10%, till 2035, claims Roots Analysis

July 2022

Given the various challenges associated with co-development of companion diagnostics and drug / therapy, drug developers prefer to rely on third-party service provi... read more

The continuous and semi-continuous bioprocessing market is projected to grow at an annualized rate of 10% till 2030, claims Roots Analysis

July 2022

The surge in demand for COVID-19 vaccines has presented lucrative opportunities for both innovators and contract service providers having continuous and semi-c... read more

The oral proteins and peptides market is anticipated to grow at a CAGR of 20%, during 2022-2032, claims Roots Analysis

June 2022

The approval of three oral protein / peptide-based therapies has led to a substantial increase in the R&D initiatives being undertaken in this domain, to evaluate the use of s... read more

The opportunity within the lyophilization services market for biopharmaceuticals is projected to grow at an annualized rate of ~7%, till 2035, claims Roots Analysis

May 2022

Characterized by a rapidly growing pipeline of biosimilars and novel biologics, and the existing challenges associated with lyophiliz... read more

The intranasal therapeutics and drug delivery systems market is projected to grow at a CAGR of 18%, claims Roots Analysis

May 2022

Upon realizing the potential of this route of administration, industry stakeholders have initiated several R&D efforts focused on exploiting the use of intranasal therapeut... read more

The live biotherapeutic products and microbiome manufacturing market is projected to grow at a CAGR of 20% during 2022-2035, claims Roots Analysis

May 2022

In recent years, the potential of microbiome-based leads for the treatment of a myriad disease indications has been widely recognized, presenting lucra... read more

Nanoparticles contract manufacturing (focus on lipid and metal nanoparticles) market is anticipated to grow at a CAGR of over 8.5%, till 2035, claims Roots Analysis

May 2022

The crucial role of nanoparticles as drug delivery systems has been extensively studied; these molecules also played a key role in th... read more

The next generation complement therapeutics market is anticipated to grow at an annualized rate of >25% for drugs in advanced development stages, claims Roots Analysis

May 2022

The approval and success of Soliris® and other complement therapeutics has paved for the development of several drugs targetin... read more

The peptide therapeutics contract API manufacturing market is anticipated to grow at an annualized rate of 13.6%, claims Roots Analysis

May 2022

Given the inherent expertise of CMOs and CDMOs, they are believed to be capable of enabling reduction in product development timelines, significant cost-benefits,... read more

The pharmaceutical secondary packaging market is projected to grow at an annualized rate of 7.6% during the period 2022-2035, claims Roots Analysis

May 2022

In order to avail benefits, such as higher flexibility, reduced cost and assistance in meeting the rising demands, several pharmaceutical companies ha... read more

The singe-use upstream bioprocessing technology market is projected to grow at a CAGR of 12% till 2035, claims Roots Analysis

May 2022

Given the various benefits of single-use technology and the rising demand for biologics, the biopharmaceutical industry is gradually shifting from conventional manufactur... read more

The cell invasion and migration assays market is projected to grow at a CAGR of 8% during the period 2022-2035, claims Roots Analysis

May 2022

In recent years, the potential of cell invasion and migration assays with respect to discovery, diagnosis and screening of diseases has been widely recognized, whic... read more

The myeloid cells targeting therapeutics market is anticipated to grow at a significant pace, till 2035, claims Roots Analysis

April 2022

With the recent FDA approval of Tavenos™ for ANCA-associated vasculitis, myeloid cells have become an attractive target for pharmacological interventions, being deve... read more

The container closure integrity testing services market is projected to grow at a CAGR of 7% till 2035, claims Roots Analysis

April 2022

Patient safety is one of the critical aspects of pharmaceutical industry, which makes it imperative for drug manufacturers and packaging service providers to evaluate the ... read more

The gene-editing beyond CRISPR market is anticipated to grow at an annualized rate of 18%, claims Roots Analysis

April 2022

With the approval of HUMULIN®, the first genetically modified drug, scientific community has made significant progress in developing gene edited therapies based on programmable nucl... read more

The ADC Cytotoxic Payloads / Warheads market is anticipated to grow at a CAGR of 12.4% till 2030, claims Roots Analysis

April 2022

With six approved drugs, namely POLIVY™, LUMOXITI™, BESPONSA®, MYLOTARG™, KADCYLA®, ADCETRIS® and over 300 drugs underdevelopment, antibody drug con... read more

The biopharmaceutical excipient manufacturing market is projected to grow at an annualized rate of 5.8% during the period 2022-2035, claims Roots Analysis

April 2022

The demand for biopharmaceutical excipients has grown considerably in the past few years; they play a critical role in biologics development by... read more

The CD-47 targeting therapeutics market is projected to grow at a CAGR of 42.9%, claims Roots Analysis

April 2022

Upon realizing the potential of this novel target, industry stakeholders have initiated several R&D efforts focused on exploiting the use of CD47 as an effective biomarker for the diagnosis a... read more

The clinical trials software market is projected to be growing at a CAGR of 14%, claims Roots Analysis

April 2022

Given the limitations of current clinical trial approaches, including inefficient patient management and data handling, trial sponsors are increasingly opting for innovative technologies and soft... read more

The exosomes development and manufacturing services market is anticipated to grow a sustained rate till 2035, claims Roots Analysis

April 2022

Driven by the development of novel platforms and advanced technologies, and the application of these molecules in research activities related to therapeutics and diag... read more

The RNA targeting small molecule therapies market is projected to be worth around USD 8.3 billion in 2030, growing at an annualized rate of 35.26% during the period 2021-2030, claims Roots Analysis

January 2022

In the recent years, RNA’s potential as a target molecule for small molecules has been widely ... read more

The clinical trial planning and design services market is projected to grow at 8% CAGR by 2030, claims Roots Analysis

December 2021

Clinical studies are presently known to capture 50% share of the overall exorbitant investments required for drug development; therefore, sponsors are actively assessing available ... read more

The large volume wearable injectors market is anticipated to grow at an annualized rate of over 40%, claims Roots Analysis

December 2021

Given the growing healthcare burden related to chronic diseases, there is a need for safe devices that allow frequent or continuous medications; large volume injectors are des... read more

The teleradiology services market is projected to grow at a CAGR of 16.8% till 2030, claims Roots Analysis

November 2021

The growing demand for remote diagnosis and increased workload on radiologists has compelled hospitals / diagnostic centers to adopt teleradiology services, to not only expedite report turnar... read more

The porphyria therapies market is projected to grow at an annualized rate of 10.97% during the period 2021-2030, claims Roots Analysis

October 2021

Several novel and innovative therapeutic approaches, both small molecule and biologics, are being currently investigated at various phases of development in order... read more

The squamous non-small cell lung cancer market is projected to grow at a CAGR of 10.8% till 2030, claims Roots Analysis

October 2021

Advances in molecular biology and tumor immunology have enabled the development of NSCLC targeting therapies, which have the ability to impede cancer growth by altering chemical ... read more

The light activated therapies market is anticipated to grow at an annualized rate of 27.7% till 2030, claims Roots Analysis

October 2021

Light activated therapies are considered to be a transformative approach owing to their capability to eradicate diseased cells from the body with minimal side effects; presen... read more

The top selling biologics market is projected to be worth USD 156 billion by 2030, claims Roots Analysis

October 2021

Owing to the numerous benefits offered by biologics, this drug class has become an integral part of the overall pharmaceutical industry, having captured a significant market share over the past... read more

The RAS targeting therapies market is anticipated to grow at an annualized rate of over 50%, till 2031, claims Roots Analysis

October 2021

Given that conventional therapies have been unable to exhibit significant efficacy in the treatment of RAS mutated cancers, novel drugs, specifically targeting the RAS gene... read more

The novel ocular drug delivery devices market is projected to grow at a CAGR of 15%, till 2030, claims Roots Analysis

October 2021

The delivery of drugs in ocular regions is known to be considerably more challenging; several pharmaceutical companies are actively undertaking initiatives to identify novel approa... read more

The outsourced cell therapy consumables market is projected to grow at a CAGR of 18% during 2021-2031, claims Roots Analysis

October 2021

Amidst the COVID-19 pandemic, there has been an evident surge in the demand for high quality cell therapies intended for research and therapeutic purposes, presenting lucrat... read more

The pharmaceutical contract manufacturing market is projected to grow at an annualized rate of ~7%, till 2030, claims Roots Analysis

October 2021

Given the inherent expertise of CMOs and CDMOs, they are believed to be capable of enabling reduction in product development timelines, significant cost-benefits, as... read more

The bioprocess controllers and automation systems market is projected to grow at a significant pace by 2030, claims Roots Analysis

October 2021

Owing to their advanced features and cost saving potential, bioprocess controllers and automation systems have been adopted widely by stakeholders in order to optimize... read more

The novel drug reconstitution systems market is anticipated to grow a sustained rate, claims Roots Analysis

October 2021

Driven by the growing pipeline of lyophilized drugs, and increasing preference for self-medication, the demand for novel drug reconstitution systems is expected to rise in the coming years ... read more

The biospecimen contract research market is projected to grow at a noteworthy pace till 2030, claims Roots Analysis

September 2021

In the ongoing COVID-19 pandemic, a surge in the number of research studies has been observed, presenting lucrative opportunities for biospecimen service providers having the capabil... read more

The pharmaceutical contract research services market is anticipated to be worth USD 59 billion by 2030, growing at an annualized rate of over 10%, claims Roots Analysis

September 2021

Customized services, reduced cost and access to advanced technologies offered by contract research service providers, have promp... read more

The Fc protein and glyco-engineered antibodies market is projected to grow at a CAGR of over 30% during 2021-2030, claims Roots Analysis

September 2021

With the emergence of blockbuster drugs, such as Gazyva® (for Chronic Lymphocytic Leukemia) and POTELEGIO® (for Sézary syndrome), Fc engineered an... read more

The soft tissue sarcoma market is projected to be worth over USD 420 million in 2030, growing at an annualized rate of 27.54% during the period 2021-2030, claims Roots Analysis

September 2021

Recent advances in molecular biology have enabled researchers to develop a better understanding of the rare soft tissue s... read more

The peptide therapeutics market is projected to be worth around USD 41.7 Billion in 2030, claims Roots Analysis

September 2021

Considering the success of already approved drugs, such as Victoza® and Nplate®, and a healthy pipeline of promising candidates, the peptide therapeutics market is anticipated to... read more

The DNA damage response (DDR) targeting therapeutics market is projected to be worth USD 1.07 billion in 2030, growing at an annualized rate of 52.6% during the period 2024-2030, claims Roots Analysis

September 2021

One of the primary causes of genomic instability, a key characteristic of several types of cance... read more

The glycosylation analysis services market is projected to reach nearly USD 2.5 billion by 2030, growing at an annualized rate of over 20%, claims Roots Analysis

August 2021

The rapidly growing pipeline of recombinant glycoprotein therapeutics, especially the glycoengineered variants of COVID-19 drugs, has pr... read more

The global cell therapy packaging services market is projected to be worth USD 1.1 billion in 2030, growing at a CAGR of ~19%, claims Roots Analysis

August 2021

With the growing pipeline of cell therapy products as potential treatments options for a myriad of diseases, drug developers are likely to collaborat... read more

The CRISPR based therapeutics market is projected to be worth around USD 2.2 billion by 2030, growing at an annualized rate of 129.2%, claims Roots Analysis

August 2021

Considering its potential to intricately alter genetic DNA, the CRISPR technology is being widely used to develop viable therapeutics for th... read more

The polycystic ovary syndrome market is anticipated to be worth USD 5 billion by 2031, growing at an annualized rate of 4%, claims Roots Analysis

July 2021

Polycystic ovary syndrome affects 1 in 10 women of childbearing age. The exact cause of the condition is unknown; however, obesity, high levels of infla... read more

The opportunity within the display library technologies and services market is projected to be USD 382 million by 2030, claims Roots Analysis

July 2021

Given the various limitations of the conventional drug discovery methods, the innovator companies are increasingly adopting the advanced technologies, such ... read more

The TIL-based therapies market is projected to be worth over USD 4.3 billion by 2030, claims Roots Analysis

July 2021

Driven by the potential to confer sustained therapeutic effects and thereby, facilitate prolonged periods of remission, TIL-based therapies have received significant financial support, and p... read more

The antibody purification services market is projected to be worth USD 2.02 billion by 2030, growing at an annualized rate of ~10%, claims Roots Analysis

July 2021

Amidst the COVID-19 pandemic, there has been an evident surge in demand for standard quality antibodies for research, diagnosis and therapeutic ... read more

The vascular disrupting agents market is projected to be worth USD 2 billion by 2030, growing at an annualized rate of over 60%, claims Roots Analysis

July 2021

Vascular disrupting agents (VDAs) are the novel oncology drugs being developed to more specifically combat complex, life threatening cancer indicat... read more

The biopharmaceutical CROs market is projected to be worth USD 67 billion by 2030, claims Roots Analysis

July 2021

Over past few years, pharmaceutical companies have outsourced various aspects of their R&D and clinical research processes to specialty contract research service providers, in order to rema... read more

The cell therapy manufacturing market is projected to reach USD 14.5 billion by 2030, growing at an annualized rate of 18%, claims Roots Analysis

July 2021

Given the consistent increase in number of cell therapies being developed and launched, this upcoming therapeutic segment is on its way to becoming one ... read more

The immunocytokines market is estimated to be worth around USD 5.4 billion by 2030, claims Roots Analysis

July 2021

Advances in molecular biology and tumor immunology have enabled the development of therapeutic fusion proteins, having the ability to activate immunologically cold microenvironments without t... read more

The biologics fill / finish services market is projected to reach over USD 10 billion by 2030, growing at an annualized rate of 10%, claims Roots Analysis

May 2021

Amidst the COVID-19 pandemic, there has been an evident surge in demand for both vaccines and certain antibody therapeutics, which has presente... read more

The modular facility manufacturing market is projected to be worth over USD 6.4 billion by 2030, growing at a CAGR of 8.8%, claims Roots Analysis

May 2021

Modular facilities offer the means for drug developers / manufacturers to ensure product quality, and flexibly use available infrastructure, thereby, en... read more

The cloud-based solutions for drug discovery, development and manufacturing market is projected to grow at a CAGR of 15.42%, claims Roots Analysis

May 2021

The growing complexities surrounding modern therapy development initiatives have caused biopharmaceutical companies to adopt available cloud-based solu... read more

The global eLearning market is projected to reach USD 420 billion by 2030, growing at an annualized rate of 8.0%, claims Roots Analysis

May 2021

The eLearning business is mostly driven by corporate training initiatives and distance education programs, leading to the development of cost friendly learning s... read more

The viral and non-viral vector manufacturing market is projected to grow at an annualized rate of over 15%, claims Roots Analysis

May 2021

The rapidly growing pipeline of genetically modified therapies reflects the surge in demand for high quality vectors, presenting lucrative opportunities for companies w... read more

The targeted protein degradation enabling technologies market, featuring a healthy pipeline of novel therapeutics, is anticipated to be worth over USD 3.3 billion by 2030, predicts Roots Analysis

May 2021

Targeted protein degradation has emerged as a revolutionary pharmacological concept that presents bot... read more

The CAR-T therapies market is characterized by a healthy pipeline of promising therapies, and is projected to be worth around USD 14 Billion in 2030, claims Roots Analysis

April 2021

Given the success of approved CAR-T cell therapies, such as KYMRIAH®, YESCARTA®, TECARTUS® and BREYANZI®, this... read more

The global digital biomarkers market is projected to be worth over USD 22 billion by 2030, growing at a CAGR of 35.74%, claims Roots Analysis

February 2021

Advances in information technology and biomedical science have enabled the development of digital solutions for biomarkers, which, owing to the myriad of pe... read more

The real world evidence (RWE) market is projected to be worth USD 4.5 billion by 2030, growing at a CAGR of 15%, claims Roots Analysis

February 2021

In modern healthcare, the applications of real world data-based insights are vast, ranging from drug discovery to supporting regulatory decision-making; in fact, t... read more

The targeted drug delivery devices market for biologics is projected to be worth around USD 5 billion in 2030, claims Roots Analysis

February 2021

Driven by the urgent need to address off-target toxicity-related concerns and improve therapeutic outcomes of biologic drugs, several patient-centric medical device... read more

The global mRNA therapeutics and vaccines market is projected to be worth around USD 10 billion in 2021, claims Roots Analysis

February 2021

mRNA as a therapeutic / preventive agent has been demonstrated to be well tolerated in vivo, and can harness the cell’s translational machinery to invoke humoral an... read more

The diabetes drug delivery devices market is projected to be worth USD 31 billion by 2030, growing at a CAGR of 9%, claims Roots Analysis

February 2021

The anticipated growth in global diabetic patient population is likely to result in a significant rise in demand for novel, safe and more patient friendly drug ... read more

The diabetes monitoring devices market is projected to grow at a CAGR of 8%, claims Roots Analysis

February 2021

The anticipated growth in the global diabetic patient population is likely to translate into significant rise in demand for advanced, cost-effective and more patient friendly solutions for disease mo... read more

The global, handheld X-ray imaging devices market is projected to be worth USD 2.8 billion by 2030, growing at a CAGR of 12%, claims Roots Analysis

February 2021

Besides portability, handheld X-ray scanners offer a wide range of benefits, including cost savings; in the initial days of the pandemic, such devices... read more

The gene therapy market is projected to be worth USD 14.6 billion in 2030, growing at a CAGR of 30%, over the next decade, claims Roots Analysis

January 2021

Driven by the potential treat the root cause of diseases, including rare clinical conditions and those that were previously deemed incurable, the gene t... read more

The market for 3D cell culture products is estimated to be worth USD 6.8 Billion by 2030, growing at an annualized rate of over 15.5%, claims Roots Analysis

October 2020

Advances in 3D cell culturing, have led to the discovery of better scaffold fabrication techniques and also enabled various parts of the pro... read more

The human factors engineering and usability testing services market for medical devices is projected to reach USD 1 Billion by 2030, claims Roots Analysis

October 2020

Human factors engineering and usability testing have now become an essential part of product design across almost all industries, offering dev... read more

The STING pathway targeting technologies market, featuring a healthy pipeline of therapeutics, is anticipated to be worth over USD 2.8 billion by 2030, predicts Roots Analysis

October 2020

STING pathway modulation, using appropriate pharmacological interventions, has emerged as a viable approach to harnessing ... read more

The global (Artificial Intelligence) AI in energy market is projected to reach USD 30.8 billion by 2030, growing at an annualized rate of 30.6%, claims Roots Analysis

October 2020

Growing awareness of the impending energy crisis and the need to reduce carbon emissions, have led to the development of AI-based ... read more

The microbial contract biomanufacturing market is projected to be worth USD 9.3 billion by 2030, growing at a CAGR of 8.7%, claims Roots Analysis

October 2020

The growing pipeline of biologics that can be produced in microbial systems, such as antibody fragments and plasmid-based therapies, is anticipated to o... read more

The opportunity for AR / VR based digital marketing service providers in healthcare sector is projected to be worth USD 3 billion by 2030 at significant CAGR of 26% claims, Roots Analysis

September 2020

Given the present scenario, many stakeholders are adopting such advanced marketing strategies to drive better ... read more

Growing at an annualized rate of over 10%, the nuclear medicine and radiopharmaceuticals manufacturing market is estimated to reach over USD 6 Billion by 2030, claims Roots Analysis

September 2020

The recent surge in the demand of radiopharmaceuticals for diagnostic and therapeutic applications, coupled with th... read more

Growing at an annualized rate of over 9%, the antibody discovery services market is projected to be worth USD 6.5 billion by 2030; further, the antibody discovery platforms market is estimated to be worth close to USD 6 billion by 2030, claims Roots Analysis

September 2020

High target specificity and favorable ... read more

The global psychedelic therapeutics market is projected to be worth over USD 6.5 billion by 2030, growing at an annualized rate of nearly 15%, claims Roots Analysis

September 2020

Till date, nearly 150 types of psychedelic therapeutics have been identified and there is a growing body of evidence supporting the ... read more

Growing at an annualized rate of 14.7%, the drug repurposing service providers market is expected to be worth over a billion dollars by 2030, claims Roots Analysis

September 2020

Given the success of approved repurposed therapeutics, such as Viagra® and Thalomid®, this approach has become a key lifecycle... read more

The global collaborative robots (cobots) market is projected to be worth USD 18 billion by 2030, claims Roots Analysis

August 2020

Over the years, various industry stakeholders have actively invested in the development and implementation of automation technologies for manufacturing operations, in order to min... read more

The high energy / hazardous chemistry-based API manufacturing services market is anticipated be worth USD 29 billion by 2030, growing at an annualized rate of ~8%, claims Roots Analysis

August 2020

As more complex new chemical entities (NCEs) are being developed for pharmacological use, the demand for high en... read more

The global digital therapeutics market is projected to be worth over USD 8.86 billion by 2030, growing at a CAGR of 19.7%, claims Roots Analysis

August 2020

Recent advances in information technology and biomedical science have enabled the development of a number of versatile digital solutions that are capable... read more

The viral vector purification products market is projected to be worth around USD 500 Million by 2030, claims Roots Analysis

August 2020

Rising demand for viral vectors coupled to lack of scalability and other concerns related to downstream purification, have led stakeholders in this domain to undertake vari... read more

The contract manufacturing market for live biotherapeutics and microbiome products is estimated to be worth USD 300 million by 2030, growing at a CAGR of 46%, claims Roots Analysis

August 2020

With over 85 microbiome-based, live biotherapeutic products under preclinical and clinical development, the demand f... read more

The novel vaccine delivery devices market is projected to be worth USD 1.5 billion by 2030, growing at a CAGR of 20%, claims Roots Analysis

July 2020

Given the anticipated increase in demand for vaccines, stakeholders are actively focusing on the development and validation of novel delivery devices, in orde... read more

The pharmaceutical contract manufacturing market in China is anticipated to be worth USD 13 Billion by 2030, growing at an annualized rate of ~8.9%, claims Roots Analysis

July 2020

Reduced manufacturing costs, availability of cheap and skilled labor, coupled to a supportive regulatory landscape has compelle... read more

The proteome profiling services market is projected to be worth USD 16 billion by 2030, growing at a CAGR of 15%, claims Roots Analysis

July 2020

Proteome profiling is a technically complex and financially demanding field of research; as a result, both pharmaceutical companies and research institutes prefer... read more

The Chinese biopharmaceutical contract manufacturing market is anticipated to be worth USD 2.6 Billion by 2030, growing at an annualized rate of 12.7%, claims Roots Analysis

June 2020

Reduced manufacturing costs, availability of cheap and skilled labor and a supportive regulatory landscape in China has comp... read more

Growing at an annualized rate of 11.2%, the peptide therapeutics contract API manufacturing market is expected to be worth USD 3.2 billion by 2030, claims Roots Analysis

June 2020

Given the success of approved peptide therapeutics, such as Victoza® and Nplate®,  the manufacturing demand has sub... read more

The medical device CRO market is projected to reach USD 15.7 billion by 2030, growing at an annualized rate of 6.4%, claims Roots Analysis

June 2020

Owing to the numerous complexities associated with clinical research, medical device developers rely on contract service providers in order to reduce the risk... read more

The subcutaneous biologic drugs and affiliated technologies market is estimated to be worth over USD 180 billion by 2030, claims Roots Analysis

June 2020

The growing pipeline of therapeutics designed for subcutaneous delivery, coupled to the rising preference for self-medication, is expected to present lucr... read more

The cell reprogramming services and products market is projected to be worth USD 2.3 billion, growing at a CAGR of 7%, claims Roots Analysis

June 2020

Empowered by technical developments in the field of biotechnology and the market opportunity associated with regenerative medicine, a number of research grou... read more

The endocannabinoid system targeted therapeutics market is projected to be over USD 5 billion by 2030, growing at an annualized rate of 30%, claims Roots Analysis

May 2020

So far, more than 100 different types of cannabinoids have been identified and there is a growing body of evidence supporting the bene... read more

The non-viral transfection reagents and systems market is projected to be worth USD 1.4 billion by 2030, growing at a CAGR of 9.2%, claims Roots Analysis

May 2020

Given the evident immunogenicity, cytotoxicity and high production cost based concerns associated with viral vectors, companies are compelled to... read more

Growing at an annualized rate of 12%, the HPAPI and cytotoxic drugs contract manufacturing market is projected to reach USD 25 billion by 2030, claims Roots Analysis

May 2020

With over 1,000 highly potent drugs in the development pipeline, the demand for developing and manufacturing of such products is an... read more

Growing at an annualized rate of 10%, the fragment-based drug discovery market is estimated to be worth around USD 1.6 billion by 2030, claims Roots Analysis

May 2020

Traditional drug discovery is associated with exorbitant investments, prolonged lead evolution timelines and high attrition rates; the frag... read more

Growing at an annualized rate of over 15%, the continuous manufacturing market is estimated to be worth around USD 2 Billion by 2030, claims Roots Analysis

May 2020

Compared to batch production methods, continuous manufacturing is not only more time-efficient, but is also associated with reduced energy nee... read more

The global electric vehicle charging infrastructure market is projected to reach USD 140 billion by 2030, growing at an annualized rate of 31.2%, claims Roots Analysis

April 2020

Increasing awareness related to the importance of reducing carbon footprint across the globe, has compelled individuals to adopt ... read more

The oligonucleotide synthesis, modification and purification services market is expected to grow at an annualized rate of over 10%, claims Roots Analysis

April 2020

The rapidly growing demand for oligonucleotides, coupled to complex manufacturing procedures and high capital investments required for setting u... read more

The next generation immune checkpoint inhibitors and stimulators market is projected to be worth USD 12.5 billion, growing at a CAGR of 15%, claims Roots Analysis

April 2020

The success of CTLA4, PD-1, and PD-L1 inhibitors paved the way for researchers to explore the vast therapeutic potential of immune che... read more

The RNAi therapeutics market is anticipated to grow at an annualized rate of more than 45%, till 2030, claims Roots Analysis

April 2020

The recent approval of first RNAi therapeutic, ONPATTROTM, has caused a surge in interest of the industry / non-industry players in upcoming field of pharmacological resear... read more

Growing at an annualized rate of over 10%, the prefilled syringe fill / finish services market is estimated to reach close to USD 3 Billion by 2030, claims Roots Analysis

March 2020

Driven by the growing pipeline of injectable drugs, and increasing preference for self-medication, the demand for fill/finish s... read more

In silico drug discovery services market is likely to be worth USD 124 million by 2030, growing at an annualized rate of 15.6%, claims Roots Analysis

March 2020

Owing to their cost and time saving potential, in silico tools are widely used in modern pharmacological research; several companies have developed ... read more

Growing at an annualized rate of nearly 10%, the companion diagnostics services market is estimated to reach USD 800+ Million by 2030, claims Roots Analysis

March 2020

Outsourcing is presently considered the preferred business model for the development of companion diagnostic tests for personalized therapeu... read more

The contract regulatory affairs-management services market for medical devices is estimated to be worth USD 820 million by 2030, growing at a CAGR of 6.9%, claims Roots Analysis

March 2020

In order to reduce risk of device recalls and expedite time to market, medical device developers rely on contract servi... read more

With over 280 therapies under evaluation, the stem cell therapy market is estimated to be worth USD 8.5 Billion by 2030, claims Roots Analysis

March 2020

The success of approved stem cell therapies has caused a surge in interest of biopharma developers in this field; many innovator companies are currently pr... read more

Driven by the growing research and development efforts by global players, therapeutic agent for novel coronavirus (COVID-19) could soon be approved, claims Roots Analysis

February 2020

With multi-billion funding initiatives publicly disclosed by various government agencies, and private investors, various leadin... read more

The next-generation sequencing market is projected to be worth USD 19 billion, growing at a CAGR of more than 15% till 2030, claims Roots Analysis

February 2020

The genome sequencing domain has witnessed a surge in the availability of service providers, With gene sequencing costs having come down by several ord... read more

The antibody contract manufacturing market is projected to reach USD 13.8 billion by 2030, growing at an annualized rate of 9.5%, claims Roots Analysis

February 2020

With over 100 therapeutic monoclonal antibodies and antibody-based products in the market, the demand for developing and manufacturing of such pr... read more

The global colocation datacenter market is projected to reach USD 170 billion by 2030, growing at an annualized rate of 13.6%, claims Roots Analysis

January 2020

The current rate of data generation, coupled to the growing concerns regarding its safety, are anticipated to propel the growth of the colocation da... read more

The global smart lighting market is projected to reach USD 80.9 Billion by 2030, growing at an annualized rate of 22.3%, claims Roots Analysis

January 2020

Increasing demand for energy efficient lighting solutions and growing number of smart city projects across the globe are amongst the key drivers behind th... read more

The autoinjectors market is projected to be worth around USD 1.5 Billion by 2030, claims Roots Analysis

January 2020

Rise in prevalence of chronic diseases and the corresponding need to medicate frequently, have led to an increase in demand for safe, self-administrable dosing options. Autoinjectors are conside... read more

The DNA-encoded libraries platforms and services market is projected to be reach USD 4 billion by 2030, growing at an annualized rate of 17%, claims Roots Analysis

January 2020

Using DNA to develop encoded libraries of pharmacological leads has enabled medical research community to assemble and maintain large ... read more

The prefilled syringes market is estimated to be worth over USD 2.5 billion by 2030, claims Roots Analysis

January 2020

Prefilled syringes present an attractive packaging option that doubles as an easy-to-use drug delivery device, and a product life cycle management tool. Consequently, they have become indisp... read more

Growing at an annualized rate of over 20%, the cell therapy manufacturing market is estimated to reach close to USD 10 Billion by 2030, claims Roots Analysis

November 2019

The approval of KYMRIAH®, YESCARTA®, Alofisel® and Zyntelgo® has increased the interest of pharma stakeholders in cell ther... read more

The global automotive lithium-ion battery market is projected to reach USD 95.3 Billion by 2030, growing at an annualized rate of 17.1 %, claims Roots Analysis

November 2019

The growing global urgency to reduce carbon footprint, coupled to the long life and low maintenance requirements of lithium ion batteries,... read more

The cell and advanced therapies supply chain management market is anticipated to grow at an annualized rate of 11% till 2030, claims Roots Analysis

November 2019

Over time, biopharmaceutical companies have realized the importance of integrating advanced software into the cell and advanced therapies supply chai... read more

Human Microbiome-based Products Market is projected to be worth over USD 4 Billion by 2030, growing at an annualized rate of over 40%, claims Roots Analysis

November 2019

Over the years, extensive R&D efforts have established the basis for a wide range of microbiome-based therapeutic and diagnostic product... read more

The non-invasive cancer diagnostics market is projected to grow at annualized rate of nearly 20%, between 2019 and 2030, claims Roots Analysis

November 2019

Given the invasive and cost-intensive nature of tissue biopsies, there is a significant unmet need for safer and more patient-friendly cancer diagnostics ... read more

The Needle-free injection systems and microneedle devices markets are projected to grow at annualized rates of nearly 15% and 20%, respectively, claims Roots Analysis

October 2019

Over the years, there has been a rise in preference for self-administration of drugs / therapies, resulting in an increasing deman... read more

The viral and non-viral vector manufacturing market is anticipated to grow at an annualized rate of over 20%, claims Roots Analysis

October 2019

The recent surge in interest in genetically-modified therapies has resulted in a steep rise in demand for different vectors for fundamental and pharmacological resear... read more

The contract manufacturing services market for stem cells is expected to be worth over USD 2.5 billion by 2030, claims Roots Analysis

August 2019

Driven by a robust and growing pipeline of stem cell therapies, the demand for development and manufacturing services for such advanced product candidates is antici... read more

The antibody drug conjugates market is projected to be worth more than USD 15 Billion by 2030, growing at a CAGR of over 20%, claims Roots Analysis

August 2019

The growing popularity and therapeutic potential of antibody drug conjugates (ADCs) is evident in the rapid growth in intellectual capital, financing... read more

The large volume wearable injectors market is anticipated to grow at a CAGR of 40%, claims Roots Analysis

August 2019

The shift to self-administration of medication, coupled to the need to improve therapy adherence, have driven device developers to design versatile drug delivery devices capable of minimizing ... read more

The gene therapy market is projected to be worth USD 10 Billion by 2030, growing at an annualized rate of over 40%, claims Roots Analysis

August 2019

The success of the approved gene therapies has led to an upward surge in the interest of biopharmaceutical developers in this field, resulting in a significant... read more

The CAR-T therapies market is projected to reach USD 11 Billion by 2030, growing at an annualized rate of 31%, claims Roots Analysis

August 2019

Given the recent success of KYMRIAH® and YESCARTA®, the current focus is on establishing a sustainable chimeric antigen receptor T (CAR-T) cell therapy mark... read more

The vector manufacturing market is anticipated to be worth USD 1.65 billion by 2030, growing at an annualized rate of over 20%, claims Roots Analysis

August 2019

Given the rise in clinical R&D activity focused on gene therapies and other advanced therapy medicinal products, there has been a surge in deman... read more

The ready-to-use primary packaging market is anticipated to be worth USD 1.6 billion by 2030, growing at an annualized rate of 11.9%, claims Roots Analysis

August 2019

Owing to the benefits offered in terms of streamlining pharmaceutical filling operations and cutting down on associated costs, pre-sterilized ... read more

The medical device contract manufacturing market is projected to reach USD 126 Billion by 2030, growing at an annualized rate of 8%, claims Roots Analysis

August 2019

Owing to numerous technical and regulatory challenges related to the development and production of medical devices, outsourcing has become a po... read more

The cell therapy manufacturing market is projected to reach close to USD 11 Billion by 2030, growing at an annualized rate of 14.9%, claims Roots Analysis

August 2019

Having demonstrated the ability to offer improved treatment related outcomes and also enhance the quality of lives of patients suffering from ... read more

Abuse deterrent formulation technologies market is projected to grow at a healthy annualized rate of 16% till 2030, claims Roots Analysis

August 2019

Advances in biotechnology and genome analysis have enabled the identification of several novel cancer biomarkers, which are presently being used for a variety o... read more

The contract manufacturing services market for vaccines is expected to grow at an annualized rate of over 10%, claims Roots Analysis

August 2019

The steadily growing demand for vaccines, coupled to the discovery and development of a variety of both preventive and therapeutic vaccine products, has generated a ... read more

With over USD 4 billion in capital investment, the synthetic lethality-based drugs market is poised to witness a rapid growth, claims Roots Analysis

August 2019

Advances in screening technologies have enabled the identification of interactive gene combinations, enabling the development of lead candidates that... read more

With over USD 1 billion in capital investment, and a rich intellectual property portfolio (~3,000 patents), the novel cell sorting and separation market is anticipated to witness significant growth, claims Roots Analysis

August 2019

Having demonstrated the ability to rapidly isolate rare cells from tissue sa... read more

The market for elastomeric closures for pharmaceutical packaging is projected to grow to USD 9.3 Billion by 2030, claims Roots Analysis

August 2019

Driven by the growing complexity of modern pharmacological interventions, industry stakeholders have turned to more versatile materials for the fabrication of co... read more

The T-cell immunotherapies market is projected to reach USD 26 Billion by 2030, growing at an annualized rate of 41.5%, claims Roots Analysis

August 2019

Having demonstrated the ability to selectively eradicate tumor cells from the body with minimal treatment-related side effects, T-cell therapies have emerg... read more

Cancer biomarkers market for TMB, MSI / MMR and TILs is projected to be worth over USD 860 Million by 2030, growing at an annualized rate of 18.3%, claims Roots Analysis

July 2019

Advances in biotechnology and genome analysis have enabled the identification of several novel cancer biomarkers, which are pre... read more

Neoantigen targeted therapies market projected to reach USD 2.9 Billion by 2030, growing at an annualized rate of 57%, claims Roots Analysis

June 2019

Advances in bioinformatics and genomic data analysis have enabled the identification of cancer antigens that are generally overlooked during immune surveill... read more

Driven by the growing demand for personalized therapies, the companion diagnostics market is anticipated to grow at an annualized rate of ~7.5%, predicts Roots Analysis 

May 2019

Roots Analysis has announced the addition of “Companion Diagnostics Market (2nd Edition), 2019-2030” report to it... read more

With an investment of over USD 1 billion and an intellectual capital spread across ~3,000 patents, the Encapsulated Cell Therapies and Encapsulation Technologies Market is set to witness a rapid growth, predicts Roots Analysis

May 2019

Roots Analysis has announced the addition of “Cell Encapsulation... read more

Driven by the growing demand for biologics, the biopharmaceutical contract manufacturing market is expected to grow at an annualized rate of 8.1%, predicts Roots Analysis

April 2019

Roots Analysis has announced the addition of “Biopharma Contract Manufacturing Market (3rd Edition), 2019-2030” rep... read more

Next Generation Contact Lenses and Visual Prostheses Market Projected to Grow at an Annualized Rate of 20%, predicts Roots Analysis

March 2019

Roots Analysis has announced the addition of “Next Generation Contact Lenses and Visual Prostheses Market, 2019-2030” report to its list of offerings.&nbs... read more

Driven by a growing pipeline of drugs targeting various chronic disorders, the large volume wearable injectors market is anticipated to grow at a rapid pace (CAGR ~40%), predicts Roots Analysis

March 2019

Roots Analysis has announced the addition of “Large Volume Wearable Injectors Market (4th Edition)... read more

Driven by regulatory mandate, the extractables and leachables testing services market is anticipated to grow at an annualized rate of ~10%, predicts Roots Analysis

February 2019

Roots Analysis has announced the addition of “Extractables and Leachables Testing Services Market, 2018-2028” report to it... read more

The medical device CROs market projected to be worth USD 12.1 billion by 2030, predicts Roots Analysis

January 2019

Roots Analysis has announced the addition of “Medical Device CROs Market, 2018-2030” report to its list of offerings. Shifali Gupta, the principal analyst, stated, “Give... read more

Cell Therapy Manufacturing Market to be Worth USD 8 billion by 2030, predicts Roots Analysis

November 2018

Roots Analysis has announced the addition of “Cell Therapy Manufacturing Market (2nd Edition), 2018-2030” report to its list of offerings. Natasha Thakur, the principal analyst, stated, &ldq... read more

The market for blockchain platforms for genomic data management is likely to grow at a CAGR of ~43.5%, predicts roots analysis

November 2018

Roots Analysis has announced the addition of “Blockchain in Genomic Data Management: Market Landscape and Competitive Insights, 2018-2030” report to its list o... read more

Real World Evidence (RWE) Solutions Likely to Grow at a CAGR of 14.1% and Significantly Drive Healthcare Decision-Making, predicts Roots Analysis

October 2018

Roots Analysis has announced the addition of “Real World Evidence: Market Landscape and Competitive Insights, 2018-2030” report to its list ... read more

Having Raised Over USD 2.6 Billion in Last Few Years, the Antibody Discovery Services Market is Poised for uninterrupted Growth, Predicts Roots Analysis

September 2018

Roots Analysis has announced the addition of “Antibody Discovery: Services and Platforms Market (2nd Edition), 2018-2028” report to i... read more

Driven by the rapidly evolving pipeline of ADC therapeutics, the ADC contract manufacturing market is anticipated to grow at an annualized rate of around 11.9% during the period 2018-2030, predicts Roots Analysis

September 2018

Roots Analysis has announced the addition of “ADC Contract Manufacturing Market... read more

Cell Therapy Manufacturing Market Projected to Grow at an Annualized Rate of 15%, predicts Roots Analysis

August 2018

Roots Analysis has announced the addition of “Cell Therapy Manufacturing Market (2nd Edition), 2018-2030” report to its list of offerings. Natasha Thakur, the principal ana... read more

Computer-Aided Drug Discovery Services Market Likely to Witness 12.4% Annualized Growth, predicts Roots Analysis

July 2018

Roots Analysis has announced the addition of “Computer-Aided Drug Discovery Services Market, 2018-2030” report to its list of offerings. Akash Mishra, the principal analy... read more

Driven by a growing pipeline of genetically-modified therapies, the vector manufacturing market is anticipated to grow at an annualized rate of over 20%, predicts Roots Analysis

May 2018

Roots Analysis has announced the addition of “Viral Vectors and Plasmid DNA Manufacturing Market (2nd Edition), 20... read more

T-Cell Immunotherapy Market Projected to Grow at an Annualized Rate of 86%, predicts Roots Analysis

May 2018

Roots Analysis has announced the release of its “T-Cell Immunotherapy Market (3rd Edition), 2018-2030”report. Pemba Lahmo, the principal analyst, stated, “With two approved th... read more

Back of the Eye Disorders, Featuring a Steadily Growing Pipeline, Likely to Witness 7.9% Annualized Growth, predicts Roots Analysis

April 2018

Roots Analysis has announced the addition of “Back of the Eye Disorders: Novel Drugs and Delivery Technologies, 2017-2030” report to its list of offerings... read more

Asthma, COPD and Cystic Fibrosis, Expected to Witness the Rise of Personalized Therapies and Smart Devices, predicts Roots Analysis

February 2018

Roots Analysis announced the addition of “Novel Drugs and Smart Devices for Respiratory Disorders, 2018-2030” report to its list of offerings. Roh... read more

3D Bioprinting: Decoding the Future Evolution

January 2018

Roots Analysis has announced the addition of 3D Bioprinting: Technologies, Products and Key Application Areas, (2nd Edition), 2018-2035’ report to its list of offerings. The report provides a comprehensive analysis of the current landsc... read more

Antibody Drug Conjugates: Riding on the Second Growth Wave

November 2017

Roots Analysis has announced the addition of ‘Antibody Drug Conjugates Market (4th Edition), 2017-2030’ report to their list of offerings. The report features an extensive study on current landscape and the future out... read more

Modular Facilities: Flexible Drug Manufacturing Platforms of the Future

October 2017

Roots Analysis has announced the addition of “Modular Facilities in Pharmaceutical / Biotechnology Industry, 2017-2030”report to their list of offerings. The report features an extensive study on current landscape ... read more

Cell Line Development Services Market to Witness Steady Growth in the Coming Decade

August 2017

Roots Analysis has announced the addition of “Cell Line Development Services Market, 2017-2027” report to its list of offerings. The report features an extensive study on the rapidly growing market of c... read more

Antibody Discovery Services Market to Witness Continuous Growth in the Coming Decade

July 2017

Roots Analysis has announced the addition of “Antibody Discovery: Services and Platforms, 2017-2027” report to its list of offerings. The report features an extensive study on the current market l... read more

Rheumatoid Arthritis: Beyond TNF Inhibitors

June 2017

Roots Analysis has announced the addition of the “Rheumatoid Arthritis: Beyond TNF Inhibitors, 2016-2026” report to its list of offerings. The report provides a comprehensive analysis of the current market landscape of therapies for the treat... read more

Non-Invasive Prenatal Testing and Newborn Screening: Efficient Diagnostic Tools in Fetal and Neonatal Care

June 2017

Roots Analysis has announced the addition of “Global Non-Invasive Prenatal Testing and Newborn Screening Market, 2017-2030” report to its list of offerings. The report p... read more

The Growing Landscape of Biopharmaceutical Contract Manufacturing Market

May 2017

Roots Analysis has announced the addition of “Biopharmaceutical Contract Manufacturing Market (2nd Edition), 2017 - 2027” report to its list of offerings. The report provides an extensive study of the contract man... read more

Mapping the Rise of Non-Invasive Cancer Diagnostics

May 2017

Roots Analysis has announced the addition of “Non-Invasive Cancer Diagnostics Market (2nd Edition), 2017-2030” report to its list of offerings. The report provides a comprehensive analysis of the current landscape and future outl... read more

Deep Learning Solutions in Drug Discovery and Diagnostics are Likely to Provide Cost and Time Saving Opportunities

April 2017

Roots Analysis has announced the addition of “Deep Learning in Drug Discovery and Diagnostics, 2017-2035” report to its list of offerings. The report provides a comprehens... read more

Cell Therapy Manufacturing Market Well Set to Meet Exponential Demand

March 2017

Roots Analysis has announced the addition of “Cell Therapy Manufacturing Market, 2017-2027” report to its list of offerings. The report provides an extensive study on the current landscape of the rapidly growing mark... read more

New Generation Antibacterials to Witness Annualized Growth of Over 30%, reports Roots Analysis

February 2017

Roots Analysis has announced the addition of “Antibacterial Drug Resistance: Market Landscape, Challenges and Upcoming Opportunities, 2016-2026” report to its portfolio. The report provides a... read more

T-Cell Immunotherapy: Harnessing the Potential of Immune Cells in the Fight against Cancer

January 2017

Roots Analysis has announced the addition of the “T-Cell Immunotherapy Market, 2017-2030 (2nd edition)” report to its portfolio. The report features an extensive study of the current market lands... read more

Prefilled Syringes Market to Grow at 3.9% Annually, predicts Roots Analysis

January 2017

Roots Analysis has announced the addition of the “Prefilled Syringes Market (4th Edition), 2017-2026” report to its list of offerings. The report provides a comprehensive analysis of the current state and ... read more

Viral Vectors and Plasmid DNA Manufacturing to Witness 16% Annual Growth, predicts Roots Analysis

November 2016

Roots Analysis has announced the addition of the “Viral Vectors and Plasmid DNA Manufacturing Market, 2016-2026” report to its portfolio. The report features an extensive study of the rapi... read more

Smart Wearables: The Future of Personalized Healthcare

October 2016

Roots Analysis has announced the addition of the “Smart Wearables in Healthcare, 2016-2030” report to its list of offerings. The report provides a comprehensive analysis of the current market landscape with respect to key players a... read more

HDAC Inhibitors: Controlling Disease Propagation by Regulating Gene Expression

September 2016

Roots Analysis has announced the addition of the “HDAC Inhibitors Market, 2016-2026” report to their list of offerings. It provides a comprehensive study on the current landscape of the evolving pipeline in ... read more

Novel Drugs and Devices to Lower Intraocular Pressure: Revolutionary Advances Poised to Grow at a Rapid Rate

September 2016

Roots Analysis has announced the addition of the “Novel Drugs and Devices to Lower Intraocular Pressure, 2016 - 2026” report to its list of offerings. The report provides a deta... read more

Non-Insulin Therapies for Diabetes: Growth Drivers and Future Outlook

August 2016

Roots Analysis has announced the addition of “Non-Insulin Therapies for Diabetes: GLP-1 Agonists, DPP4 Inhibitors and SGLT2 Inhibitors, 2016 - 2026” report to its portfolio. The report provides a comprehensive analys... read more

Vaccine Contract Manufacturing: A Niche Segment Poised to become a Global Market by 2026

July 2016

Roots Analysis has announced the addition of the “Vaccine Contract Manufacturing Market, 2016-2026” report to its list of offerings. The report provides an extensive study of the current market lan... read more

Autoinjectors Market to Grow at 8% Annually, predicts Roots Analysis

June 2016

Roots Analysis has announced the addition of “Global Autoinjectors Market, 2016-2026” report to its portfolio. The report provides a comprehensive analysis of the current state of autoinjectors market and the lik... read more

HPAPIs and Cytotoxic Drugs: The Growing Opportunity for Contract Manufacturers

March 2016

Roots Analysis has announced the addition of HPAPIs and Cytotoxic Drugs Manufacturing Market, 2016-2026 (2nd edition)  report to its portfolio. The report provides an extensive study of the contract ... read more

Specialty CROs: The future of R&D Outsourcing

March 2016

Roots Analysis has announced the addition of Specialty CROs Market, 2016-2025 report to their offering. The report delivers a comprehensive study on Contract Research Organizations (CROs) that offer specialized sets of research capabilities/s... read more

Peptide Therapeutics: The Growing Hope for Metabolic Disorders

February 2016

Roots Analysis has announced the addition of “Peptide Therapeutics in Metabolic Disorders, 2016-2025” report to its portfolio. The report provides a comprehensive study on the current market landscape and the future outlook... read more

Microbiome Therapeutics Market: What's the Future Potential?

January 2016

Roots Analysis has announced the addition of “Microbiome Therapeutics Market, 2015-2030” report to their offering. The report provides a comprehensive study on the current landscape and the future outlook of the evolving pipe... read more

RNAi Therapeutics Market to be Worth USD 18.6 Billion by 2030, predicts Roots Analysis

December 2015

Roots Analysis has announced the addition of “RNAi Therapeutics Market, 2015-2030” report to their offering. The study offers a comprehensive analysis of the current landscape and future outlook of t... read more

The Future Potential of Non-invasive Cancer Diagnostics

November 2015

Roots Analysis has announced the addition of “Non-invasive Cancer Diagnostics Market, 2015-2030” report to their offering. The report offers an extensive study of several commercialized and / or under development non-invasive diag... read more

T-Cell Immunotherapy Market to be Worth USD 30 Billion by 2030, predicts Roots Analysis

October 2015

After the early success of Immune Checkpoint Inhibitors, T-cell immunotherapy has emerged as another innovative and potent arm of the immuno-oncology market. Characterised by key features such as target specifi... read more

NASH drugs market could be worth USD 30 billion, predicts Roots Analysis

October 2015

Roots Analysis has announced the addition of “NASH Drugs Market, 2015-2025” report to their offering. The study offers a comprehensive analysis of the current landscape and future outlook of the evolving pipeline ... read more

Immune Checkpoint Inhibitors: A New Hope for Cancer Patients

September 2015

Roots Analysis has announced the addition of “Immune Checkpoint Inhibitors Market (2nd edition), 2015-2025” report to its portfolio. The study provides a comprehensive analysis of the current market landscape and fu... read more

3D Cell Cultures: Novel Approaches and Opportunities Ahead

June 2015

Roots Analysis has announced the addition of “3D Culture Market, 2015-2025” report to their offering. The 3D culture approach is emerging as a promising tool that surmounts the limitations posed by monolayer or 2D culture syste... read more

Sustained Release Ocular Drug Delivery: Mapping the Future Potential

June 2015

Roots Analysis has announced the addition of “Sustained Release Ocular Drug Delivery Systems Market, 2015-2025 (2nd edition)” report to their offering. The report provides an extensive study of the emerging marke... read more

Blood Brain Barrier Technologies: Novel CNS Drug Delivery Approaches

May 2015

Roots Analysis has announced the addition of “BBB Technologies: Novel CNS Drug Delivery Approaches, 2015 - 2030” report to its portfolio.  The report provides an extensive study of the emerging market of BBB... read more

Biopharmaceutical Contract Manufacturing: Key Growth Areas

May 2015

Roots Analysis has announced the addition of ‘Biopharmaceutical Contract Manufacturing Market, 2015-2025’ report to their offering. The report provides an extensive study of the contract manufacturing opportunity for this ... read more

Non-Tyrosine Kinase Inhibitors Market to Witness 9% Annualized Growth, predicts Roots Analysis

April 2015

Roots Analysis has announced the addition of “Non-Tyrosine Kinase Inhibitors in Oncology, 2015-2025” report to their offering.  The report provides a comprehensive analysis of the curren... read more

Gene Therapy Market to be Worth over USD 10 billion by 2025, predicts Roots Analysis

March 2015

Roots Analysis has announced the addition of “Gene Therapy Market, 2015-2025” report to their offering. The market currently has only five approved therapies; of these, four are commercialised in geogr... read more

Rare Diseases: The Pharmaceutical Landscape and Opportunity Areas

February 2015

Roots Analysis has announced the addition of “Rare Diseases: The Pharmaceutical Landscape and Opportunity Areas” report to its portfolio. The report provides a comprehensive study of the pipeline drugs being developed fo... read more

Immune Checkpoint Inhibitors Market To Witness 24.1% Annualised Growth, predicts Roots Analysis

November 2014

Roots Analysis has announced the addition of “Immune Checkpoint Inhibitors Market, 2014-2024” report to their offering. The study offers a comprehensive view of the emerging market of CTLA-4... read more

Needlestick Safety Injection Devices: Opportunities Ahead

October 2014

Roots Analysis has announced the addition of “Needlestick Safety Injection Devices, 2014 - 2024” report to their offering. The study offers a comprehensive view of the product portfolio of safety injection devices, their compara... read more

Large Volume Wearable Injectors: From Conception to Reality

September 2014

Roots Analysis has announced the addition of “Large Volume Wearable Injectors, 2014-2025” report to its portfolio. The report is the second edition of the original publication titled “Bolus Injectors, 2014-2024” re... read more

Glycated Haemoglobin (HbA1c) Testing Market to Witness 8.8% Annual Growth

August 2014

Roots Analysis has announced the addition of “Glycated Haemoglobin (HbA1c) Testing Market, 2014 - 2024” report to its portfolio.  The report provides an extensive study of the growing market for HbA1c t... read more

HPAPIs and Cytotoxic Drugs Manufacturing Market to Evolve Rapidly, reports Roots Analysis

August 2014

Roots Analysis has announced the addition of “HPAPIs and Cytotoxic Drugs Manufacturing Market” report to their portfolio.  The report provides an extensive study of the contract manufact... read more

Prefilled Syringes Market to grow to 12.4 billion units by 2024, predicts Roots Analysis

July 2014

Roots Analysis has just released the 2nd edition of its publication "Prefilled Syringes Market, 2014 - 2024 (2nd edition)", acomprehensive study on the product pipeline, technological progr... read more

Companion Diagnostics Market to grow at 22.9% over the next decade, predicts Roots Analysis

June 2014

Roots Analysis has announced the addition of “Companion Diagnostics Market, 2014 - 2024 (2nd edition)” report to their offering. The study offers an extensive analysis of this growing marke... read more

Sustained Release Ocular Drug Delivery Systems: What Lies Ahead?

April 2014

Roots Analysis has announced the addition of “Sustained Release Ocular Drug Delivery Systems Market, 2014-2024” report to their offering. The report provides an extensive study of this field, focusing on commerc... read more

The Transition Towards Single-use Bioreactors

April 2014

Roots Analysis has announced the addition of the “Single-use Bioreactors, 2014-2024” report to their offering. The report provides an extensive study of this emerging field, including detailed sales forecast of single-use bioreactors in the... read more

Antibody Drug Conjugates: Contract manufacturing market to evolve rapidly, predicts Roots Analysis

February 2014

Roots Analysis has announced addition of the “Antibody Drug Conjugates: Contract Manufacturing Market, 2014-2024” report to their offering. The report provides an extensive stud... read more

The Rise of Oral Proteins and Peptides

November 2013

A new report published by Roots Analysis provides a comprehensive view of the emerging market of “Oral Proteins and Peptides”. Apart from profiling the various drugs which are in different stages of clinical trials, the study also talks about many... read more

Bolus Injectors: The Next Billion Dollar Opportunity

October 2013

Roots Analysis latest publication on “Bolus Injectors” predicts that the market for these devices is likely to be ~USD 8.8 billion by 2024. Also known as ‘patch pumps’ and ‘large volume injectors’, the first c... read more

Bispecific Antibodies market to be worth USD 4.4 billion by 2023, predicts Roots Analysis

September 2013

Roots Analysis has announced addition of the “Bispecific Antibody Therapeutics Market, 2013-2023” report to their offering. The report provides an extensive study of this emerging field, including... read more

Engineered Antibodies market to be worth USD 5.7 billion by 2023

September 2013

Roots Analysis has announced addition of the “Fc Protein and Glycoengineered Antibodies Market, 2013-2023” report to their offering. The report provides an extensive study of this emerging field, including detailed s... read more

Antibody Drug Conjugates market to be worth USD 9 billion by 2023: Report by Roots Analysis

July 2013

A new report published by Roots Analysis Private Limited estimates the market for Antibody Drug Conjugates (ADCs) to grow to USD 9 billion annually by 2023. The report provides an extensive study of this em... read more

Pre-filled Syringes market to be worth USD 6.9 billion in 2018

July 2013

A new report published by Roots Analysis Private Ltd. forecasts the market for prefilled syringe systems to grow at a CAGR of 13.8% during the forecast period 2012-2018. According to the report titled ‘Prefilled Syringes Wor... read more

Market for Companion Diagnostics to grow at 29.2% till 2018

June 2013

A new report published by Roots Analysis Private Ltd., a research group focused solely in the pharmaceutical industry, estimates that Companion Diagnostics market was worth USD 193 MM in 2012. This represented 10.1% of the total Personali... read more

Alzheimer's drug market to grow at 8.0% during 2012-2017

May 2013

A new report released by Roots Analysis Private Ltd. forecasts the market for Alzheimer’s drugs to grow at a CAGR of 8.0% during the period 2012-2017. According to the report titled ‘Alzheimer’s Drugs Market, 2012-2017... read more

MEDIA CITATIONS

  • We are your partners with no equity

  • We fit in your budget

  • We love what we do

  • Chance to prove ourselves

  • Best in class quality of work

  • Most trusted consulting partner in the industry

Copyright © 2023 Roots Analysis. All Rights Reserved.